The Senate version of the bill also requires that representatives of the drug industry, the diagnostic-equipment business and medical-device makers — all of which have a financial stake in the results of comparative-effectiveness research — hold seats on the governing board of the new agency in charge of it. The potential for conflict of interest has raised alarms among some in the research community. But Obama's top health adviser, Nancy-Ann DeParle, contends that it's a sign that some of comparative effectiveness's most ardent foes have come around to the idea that technologies and treatments have to prove themselves. "Ten years ago, most of the industry was dead set against this," she says. "Now they are saying, 'We want a seat at the table.' "
Of course they want a fucking seat at the table that decides whether the government will pay for the treatments they provide, you moron.
As I said, I don't understand the plan. I doubt anyone does. But I have a better grasp of money, politics and bullshit. And I see the balance tipping toward a bad bargain.
Informed and/or Ignorant opinions requested.
ETA: this is not to say that I am complacent with the status quo. I am not. I do not want things like this to happen. Yo, Congress, make it so.